Cargando…
Targeting the MHC Class II antigen presentation pathway in cancer immunotherapy
The success of immunotherapy relies on the participation of all arms of the immune system and the role of CD4+ T lymphocytes in preventing tumor growth is now well established. Understanding how tumors evade immune responses holds the key to the development of cancer immunotherapies. In this review,...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3489746/ https://www.ncbi.nlm.nih.gov/pubmed/23162758 http://dx.doi.org/10.4161/onci.21205 |